Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Andrea, Rocca"'
Autor:
Daniele Generali, Andrea Rocca, Carla Strina, Manuela Milani, Enrico Fiorino, Valeria Cervoni, Carlo Azzini, Antonella Saracino, Ingnazio Ciliberto, Nicoletta Ziglioli, Marzia Alberio, Fabiola Giudici, Martina Dester, Oriana Ciani, Giulia Fornaro, Sergio Aguggini, Christa Dreezen, Darina Pronin, Stefanie Ende
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39485- (2024)
Purpose: The aim of this study was to assess the prognostic performance of the 70-gene signature, MammaPrint, in an Italian single-center prospective cohort of early-stage intermediate-risk breast cancer (BC) patients. Methods: A total of 195 eligibl
Externí odkaz:
https://doaj.org/article/2786ca856aa34c789634138ba4c8b901
Autor:
Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Benvenuto Ferrari, Francesco Schettini, Estela Pineda, Stefano Panni, Marika Cominetti, Patrizia D’Auria, Simonetta Bianchini, Elena Varotti, Marco Ungari, Stefano Ciccarelli, Marzia Filippini, Sarah Brenna, Valentina Fiori, Tomas Di Mambro, Angelo Sparti, Mauro Magnani, Fabrizio Zanconati, Daniele Generali, Antonio Fioravanti
Publikováno v:
Cells, Vol 13, Iss 7, p 597 (2024)
Glioblastoma is the most frequent and aggressive brain tumor in adults. This study aims to evaluate the expression and prognostic impact of CD99, a membrane glycoprotein involved in cellular migration and invasion. In a cohort of patients with gliobl
Externí odkaz:
https://doaj.org/article/72f2663c2c414c968a37c62da85a97d3
Autor:
Andrea Balduit, Romana Vidergar, Paola Zacchi, Alessandro Mangogna, Chiara Agostinis, Micaela Grandolfo, Cristina Bottin, Francesco Salton, Paola Confalonieri, Andrea Rocca, Fabrizio Zanconati, Marco Confalonieri, Uday Kishore, Berhane Ghebrehiwet, Roberta Bulla
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Complement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferatio
Externí odkaz:
https://doaj.org/article/9a6b8f6959214d31bd734cc79ae1ce91
Autor:
Michela Palleschi, Andrea Prochowski Iamurri, Emanuela Scarpi, Marita Mariotti, Roberta Maltoni, Francesca Mannozzi, Domenico Barone, Giovanni Paganelli, Michela Casi, Emanuela Giampalma, Ugo De Giorgi, Andrea Rocca
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Body composition parameters (BCp) have been associated with outcome in different tumor types. However, their prognostic value in patients with HER2-positive metastatic breast cancer (BC) receiving first line treatment with dual anti-HER2 ant
Externí odkaz:
https://doaj.org/article/491eb08b4bc644f5bf11ddfefef2efc2
Autor:
Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, Andrea Rocca, Alberto D’Angelo, Fabiola Giudici, Cristina Bottin, Carmine Antonio Donofrio, Maurizio Pinamonti, Benvenuto Ferrari, Stefano Panni, Marika Cominetti, Jahard Aliaga, Marco Ungari, Antonio Fioravanti, Fabrizio Zanconati, Daniele Generali
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 311 (2023)
With the advent of immunotherapies, the field of cancer therapy has been revived with new hope, especially for cancers with dismal prognoses, such as the glioblastoma multiforme (GBM). Currently, immunotherapies should potentiate the host’s own ant
Externí odkaz:
https://doaj.org/article/765c12e4ebaf47da9beb45e9574bf7a1
Autor:
Sung Pil Hong, Thalia E. Chan, Ylenia Lombardo, Giacomo Corleone, Nicole Rotmensz, Sara Bravaccini, Andrea Rocca, Giancarlo Pruneri, Kirsten R. McEwen, R. Charles Coombes, Iros Barozzi, Luca Magnani
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
The development of resistance to endocrine therapy is a significant, clinical problem in breast cancer. Here, the authors identify a rare subpopulation of cells that drive resistance following transcriptional reprogramming.
Externí odkaz:
https://doaj.org/article/266ee5cecff04b52b1a25a258b6d6db4
Autor:
Andrea Rocca, Pietro Cortesi, Laura Cortesi, Lorenzo Gianni, Federica Matteucci, Lorenzo Fantini, Antonio Maestri, Donata Casadei Giunchi, Luigi Cavanna, Rosa Ciani, Fabio Falcini, Antonella Bagni, Elena Meldoli, Monia Dall’Agata, Roberta Volpi, Daniele Andreis, Oriana Nanni, Annalisa Curcio, Leonardo Lucchi, Dino Amadori, Anna Fedeli
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The aim of this study was to improve activity over single human epidermal growth factor receptor 2 (HER2)-blockade sequential neaodjuvant regimens for HER2-positive breast cancer, by exploiting the concomitant administration of trastuzuma
Externí odkaz:
https://doaj.org/article/80cb6bee9a8f421483a798d7d407304c
Autor:
Alberto Farolfi, Elisabetta Petracci, Luigi Serra, Alessandra Ravaioli, Sara Bravaccini, Sara Ravaioli, Maria Maddalena Tumedei, Paola Ulivi, Matteo Canale, Maurizio Puccetti, Fabio Falcini, Secondo Folli, Annalisa Curcio, Andrea Rocca
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Women with a diagnosis of ductal carcinoma in situ (DCIS) have a high risk of developing a second breast event (SBE). The immune system might play a role in trying to prevent a SBE. Patients diagnosed with DCIS were identified in the population-based
Externí odkaz:
https://doaj.org/article/1f1a5cd443a04fe4a584569091a0c592
Autor:
Roberta Maltoni, Michela Palleschi, Sara Ravaioli, Maria Maddalena Tumedei, Andrea Rocca, Elisabetta Melegari, Mattia Altini, Maurizio Puccetti, Silvia Manunta, Sara Bravaccini
Publikováno v:
Cell Transplantation, Vol 29 (2020)
Keup and colleagues provide liquid biopsy preliminary results by sequencing variants in circulating tumor cells (CTCs) and cell-free deoxyribonucleic acid (cfDNA) “all from one tube” format, in order to use the same blood sample under the same is
Externí odkaz:
https://doaj.org/article/cbd36830377747c2addfca4486d1bba4
Autor:
Sara Bravaccini, Giuseppe Bronte, Emanuela Scarpi, Sara Ravaioli, Roberta Maltoni, Anita Mangia, Maria Maddalena Tumedei, Maurizio Puccetti, Patrizia Serra, Lorenzo Gianni, Laura Amaducci, Nicoletta Biglia, Valentina Bounous, Angelo Virgilio Paradiso, Rosella Silvestrini, Dino Amadori, Andrea Rocca
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast can
Externí odkaz:
https://doaj.org/article/9c335358d56743fda946544b114d2f88